Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - CHANGE IN WORKING CAPITAL
Change in Working Capital IMVT - Immunovant, Inc.
2.63 M
LAST VALUE
-58.31%
2 YEAR CAGR
49.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR